The lack of a satisfactory animal model has greatly complicated the study of immunity to systemic meningococcal disease. Mucin-enhanced infection, albeit unsatisfactory, is the only model presently available (1) . The studies of Scherp and Rake (2), Watson and Scherp (3) , and Kabat et al. (4) with hyperimmune sera of several animal species and convalescent sera of man indicated that antibodies to the group-specific polysaccharides were able to passively protect mice against fatal meningococcal infection. Goldschneider et al. (5) have demonstrated that the presence in human serum of antibodies to meningococcal antigens, as measured by the bactericidal reaction, is strongly correlated with immunity to meningococcal disease. In many of the sera studied, it could be shown that a large part of the bactericidal antibody was directed against the group C-specific polysaccharide (6) . These lines of evidence indicate that if antibodies to the group-specific polysaccharides could be induced artificially, they probably would be protective.
Kabat et al. (7) investigated the immunogenicity of the group A polysac. charide in human volunteers. They found it to be a poor antigen. Kabat also iniected several human volunteers with the group C polysaccharide prepared by Watson and Scherp (3) . The results were equally disappointing (8) . These polysaccharides probably all had average molecular weights of less than 50,000 (9) . 1 Work on partially degraded dextrans has indicated that only if the molecular weight of polysaccharides is above 100,000 are the preparations reliably antigenic in human beings (10) . Gotschlich et al. (11) have shown that the groupspecific A and C meningococcal polysaccharides, when isolated by the method employing the cationic detergent Cetavlon, have high average molecular weights in excess of 100,000. These considerations prompted a reinvestigation of the immunogenicity in human beings of the meningococcal group A and C antigens. 
Materials and Methods
Antigens.--The group-specific meningococcal polysaccharides used in this study have been described in the preceding report (11) . Meningocoecal endotoxins were prepared by the hot phenol-water method of Westphal et al. (12) from group A and group C mertingoeocci. The organisms were grown on the defined agar medium described by Catlin and Schloer (13) , harvested in distilled water, centtifllged, and washed with distilled water. They were extracted twice with hot phenol-water mixture. The aqueous layers were pooled; dialyzed extensively against distilled water, and centrifuged at 100,000 g for 3 hr. The pellets were suspended smoothly i n 30 ml of water and ultracentrifuged for 3 hr at 100,000 g. This step was repeated once. The pellet was suspended in a minimal volume of water and lyophilyzed.
Mudn-Enhanced Infection in
Mice.--Hog gastric mucin (granular mucin type 1701-W) was purchased from Wilson Laboratories, Chicago, Ill., and prepared as a 5% suspension in water, sterilized by autoclaving, and neutralized with 1 ~ NaOH before use. Meningococci were grown for 6 hr on Mueller-Hinton agar (14) , and a suspension containing approximately 1 X 109 organisms/ml in phosphate-buffered saline was prepared as described by Goldsehneider et al. (5) . The bacterial suspension was further diluted in mucin and an aliquot was removed and plated to assay the number of viable organisms. Inbred male and female mice of strain C57BL/6 (Microbiological Associates, Walkersville, Md.), weighing 20-25 g were injected intraperitoneally with I mi of mucin containing the meningoeocei and observed for 4 days. Most deaths occurred within 48 hr.
Immuni~agion of Primates.--The immunogeulcity of group A polysaccharide lot A-1 and of C polysaceharide lot C-2 was tested in 12 rhesus monkeys weighing about 4 kg each. Three animals were injected with 25 #g of A polysaccharide intradermally, and were reinjected 25 days later with 20 #g of A polysaccharide. At the time of the second injection, they also received 2 #g of C polysaccharide intradermally. Three other monkeys had the same immunization schedule but the order of administration of the antigens was reversed. All animals were bled immediately prior to the first injection and on days 14, 25, and 40 thereafter. Six other monkeys were injected intradermally with 2 #g of the same lots of polysaceharide used above, three with the A polysaccharide and three with the C polysaecharide antigen. These animals were bled 15 and 20 days after immunization. One rhesus monkey weighing about 10 kg was injected intramuscularly with 50 #g of A polysaccharide lot A-1 absorbed onto aluminum hydroxide gel, and was bled 14 and 40 days after injection. Eight chimpanzees were injected intradermally with 50 #g of polysaceharide, four of them with the A polysaceharide antigen, lot A-5, and the other four with C polysaceharide antigen, lot C-5. Two of the chimpanzees which were injected with A polysaccharide and two injected with C polysaccharide had undergone splenectomy prior to the present study as part of a study of experimental infection with malaria. The other four animals were normal. Bleedings were obtained at the time of injection, and on days 7 and 21 after immunization.
Five gibbons at the SEATO Laboratories in Bangkok, Thailand, were injected intraderreally with 25/~g of C polysaccharide, lot C-3, and were bled at weekly intervals for 4 wk. Serological Metkods.--Passive hemagglutination was performed as described by Gotschlich et al. (11) . Polysaccharides from lot A-2 or C-2 were used to sensitize the red cells. The assay for bactericidal antibody and the hnmunofluorescent assay for antibody were performed as described by Goldschneider et al. (5) . Fluorescein-conjugated rabbit sera against the heavy chains of human immunoglobulin A, G, and M were prepared by Behringwerke, MarburgLahn, Germany, and purchased from Hoechst Pharmaceutical Co., Kansas City, Mo. These companies also supplied the plates (Partigen) and method used for quantitative radial immunodiffnsion for the determination of the amount of the various immunoglobulins in chromatographically separated serum. Human Sera.--Blood obtained from volunteers was allowed to clot at 37°C for 1 hr, centrifuged, and the major part of the serum stored frozen at --73°C. Small aliquots of serum were stored at 4°C. The latter samples were used for passive hemaggintination and for ring tests, whereas the frozen samples were used for all other studies.
Gel Filtration of Human
Cultures.--Nasopharyngeal cultures to determine the presence of meningococci were performed as described by Artenstein et al. (18) . The serological grouping was done by the method of Evans et al. (19) . (20) . The latter work has delineated the optimum dose of polysaccharide to be used for immunization (0.1-1.0 gg) and the moment of maximum immunity (1 wk after immunization) against a challenge infection with living pneumococci (20) . It has been shown that the majority of strain C57BL/6 mice succumb when injected with 10 or more meningococci suspended in 5 % hog gastric nlucin, and that these mice can be passively protected against fatal meningococcal infection by prior injection of antiserum. Several experiments were performed using this model. The results of one of these studies are shown in Table I .
RESULTS

The Immunogenicity of Higk Molecular
Mice were injected intraperitoneally with the appropriate polysaccharide. Doses of 0.05, 0.10, and 0.50 #g were employed. 1 wk later, the animals were challenged by intraperitoneal injection with approximately 100 meningococci suspended in mucin. This unusually small dose was chosen to maximize the opportunity of observing active immunity. No protective effect was observed.
In another experiment, mice immunized 1 wk before with 0.5 and 1.5/~g of A polysaccharide, lot A-l, were challenged with 1000 group A meningococci of strain A1. All the animals died. The same result occurred when mice injected with 0.1 and 1.0 #g of C polysaccharide, lot C-1, were challenged with 1000 group C meningococci of strain Cll.
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IMMUNITY TO M'ENINGOCOCCUS. IV 2. Primates: 13 rhesus monkeys were injected with various doses of the A and the C polysaccharide as described under Materials and Methods. Sera from the animals were tested for the presence of antibodies with the passive hemagglutination test. No increases in taters were observed.
Four chimpanzees were immunized with 50/,g of A polysaccharide, lot A-5, and four with an equal amount of C polysaccharide, lot C-5. None of the sera obtained from the chimpanzees showed any increases in hemagglutAnation titers.
Five gibbons were injected intradermally with 25/~g of C polysaccharide, lot C-3. No change in hemagglutination titers were observed in four of these animals. However, one gibbon had a definite immune reaction; its hemagglutina- 
Toxicity of t~ Group-Specific Meningococcal Antigens in Laboralory
Animals. --Four tests to assay the toxicity of meningococcal polysaccharides were carded out in laboratory animals; two were designed to detect contamination with biologically active endotoxin, and the other two were general toxicity tests. Toxicity controls of polysaccharides, lots C-4, C-5, and A-S, prepared expressly for human use, were performed on final packaged material, which had passed the sterility tests.
Pyrogenicity in rabbits:
A dose of 2.5 ~ag of Cat, C-S, or A-$ was injected intravenously into each of three albino rabbits. As a positive control, other rabbits were injected with 0.010/zg of endotoxin isolated from the same meningococcal strains (/tl and Cll) used for the preparation of the group-specific polysaccharides. Rectal temperatures were obtained on these animals. The results are set forth in Table II .
The nine animals injected with the polysaccharide preparations did not OOTSCHI,ICH, C~LDSCHNEIDER, AND KRTENSTEIN 1371 exhibit any perceptible pyrogenic responses. However, the six animals injected with 0.010 pg of endotoxin from strain A1 or Cll had definite febrile resPonses. This experiment indicates that the Polysaccharides contained less than 1% by weight of biologically active endotoxin.
I n h~i o n of drinking by mlc~:
The absence of significant amounts of endotoxin was also demonstrated by the test described by Dubos and Schaedler (17) . Normal mice gain weight overnight primarily because of water intake. However, animals injected with endotoxin do not drink normally and show a weight loss overnight. Mice were weighed mad injected at 4 p.m. with 100 ~g of polyssccharide or with either 1.0 or 0.5/~g of meningococcal endotoxin. Water and food were suppUed ad lib. The animals were weighed the next morning and the average weight change per mouse was calculated. The results of four experiments are shown in Table HI . The mice injected with polysaccharlde generally gained less weight than control animals injected with saline. The injection of one preparation, lot C-3, caused a loss of weight. However, in no experiment did the mice injected with polysaccharide lose as much weight as the animals injected with 0.S ~g or 1 ~ag of endotoxin 1372 IMMUNITy TO MENINGOCOCCUS. IV
Growth of weanling mice:
One of the general toxicity tests employed determined the effect upon the growth rate of weanling mice resulting from the inject-ion with meningococcal polysaccharides (16) . Male or female albino mice weighing 14-16 g were injected with 100 #g of the various lots of polysaccharide, and their weights were observed for 1 wk. used in the third and fourth experiments gained weight more slowly than males. The experiment was done twice with lot A-5. The growth rate of the mice injected with polysaccharide was no different than that of animals injected with saline.
Toxicity for guinea pigs:
The other general safety test is one required by federal regulations for biological products (15) . Three guinea pigs weighing about 350 g were injected with 500 #g of each lot of polysaccharide and their weights and temperatures were observed for 1 wk. The lots of polysaccharide C-4, C-5, and A-5 were tested by this method. The animals showed normal weight gain and no febrile responses.
GOTSCHLICH~ GOLDSCHHEIDER~ AND ARTENSTEIN
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The Immunogenicity of High Molecular Weight A and C Meningococcal Polysaccharides in Human Volunteers.--The immunogenicity of the group-specific polysaccharides was first tested in one volunteer and then in an additional five. All of the volunteers were males ranging in age from 24 to 38 yr, and were laboratory personnel. One of the subjects was a Negro, the others Caucasian. Throat cultures were obtained at the beginning of the study, at weekly intervals for 4 wk and occasionally thereafter, and were examined for the presence of meningococci (18, 19) . All cultures were negative except for subject I.G. who had recently acquired a group B meningococcus. Subject J.W. was known to have carried group C meningococci until about 4 months prior to this study. The subjects were bled and then injected intradermally in the forearm with 0.20 ml of isotonic saline containing 50 pg of polysaccharide. The dates and the sequence of immunizations are indicated in Table VII . The subjects were asked to report any signs or symptoms of toxicity and to measure their temperature 8 hr after the injection. None of the volunteers had any signs of systemic toxicity and no febrile responses occurred.
All subjects showed a skin reaction to the injections. There were no immediate wheal and erythema reactions. About 4 hr after the injection, a pale orange discoloration occurred which was limited to the site of the bleb. One subject (E. C. G. injected with A-2) reported mild itching locally which disappeared rMMUNITY TO MENINGOCOCCUS. IV within 6hr. At about 8 hr, all subjects reported an area of erythema and sometimes slight induration around the site of injection. The reactions ranged up to 50 mm in diameter, were slightly tender, and reached maximum dimensions by 20 hr. They then faded completely over the next 48 hr, leaving in most instances an area of pigmentation about 10 mm in diameter which disappeared in about 2 wk.
Serum specimens were collected at weekly intervals for 4 wk and occasionally thereafter. Antibody responses were measured by several methods, Tables V and VI show that all subjects responded with the production of hemagglutinating antibody within 1 wk of injection of polysaccharide and reached peak titers within 2 wk. The geometric mean of the reciprocal titers was 161 for the response to the C polysacchaHde, and 446 for the response to the A polysaccharide. The titers remained unchanged or dropped one 2-fold dilution during the remainder of the study. Subject J. W. was known to have been a group C carrier until a few months before this Study, and this probably accounts for his initial titer of 1/32 against red ceils sensitized with the C antigen. Due to the nature of the hemagglutination system, the other initial titers should not be interpreted as indicating either the presence or absence of antibodies. What is of interest are the pronounced increases in titer following the injection of the antigens.
HemaggluZinaZing antibodies: Results in
Precipitaging antibodies:
The sera of these subjects were also tested qualitatively for the presence of precipitating antibody employing the ring test. All subjects except J. S. had detectable precipitating antibodies to the A and the C polysaccharide within 2 wk after injection with the respective antigen. The sera of subject J. S. did not at any time produce a positive ring test with either antigen.
Bavterividal antibodies:
The bactericidal antibody response resulting from the ;mrnunizations was tested by measuring the bactericidal activity of the sera agdast four test strains of meningococci in the presence of an exogenous source of human complement. Two of the test organisms belonged to group A and the other 2 to group C. The results are set forth in Table VII . AU subjects, except E. C. G., were injected first with the C polysaccharide. Their bactericidal activities to the group C test organisms rose to full titer within a week or two. Subject J. W., who had been a group C carrier and had a very high initial bactericidal titer to the group C organisms, nevertheless experienced a considerable rise in activity after the injection with C polysaccharide. None of the subjects had increases in bactericidal activity to the group A test organisms as a result of injection with the C polysaccharide, but all volunteers did produce bactericidal antibody to the group A test organisms in response to injection with the A polysaccharide. Subject W. C. B. was not injected with the A polysaccharide and never developed increased bactericidal activity to the group A test organisms. Subject I. G. showed the same pattern of increases in bactericidal response even though he was a carrier of group B meningococci.
The order of the immunizations was reversed for subject E. C. G. and it should be noted that injection with the A polysaccharide did not increase the bactericidal activity against the group C test organisms. The bactericidal activity d the sera obtained from this subject was tested against a greater number of meningococcal strains and the results are presented in Table VIII .
After immunization with the polysaccharide antigens, there were demonstrable increases in bactericidal activity to all strains of meningococci belonging to group A or group C. However, no increases in bactericidal activity occurred to organisms belonging to group B or to 135 (19) . 32  16  16  32  16  32  64  32  16  256  512  32  128  256  256  64  256  256  512  64  256  256  512  128  256  256  512   4  8  8  4  8  16  8  64  128  64  128  8  4  64  128  256  256  64  128  256  512  64  256  256  512  128  256  128  512   8  8  4  4  8  8  64  64  8  16  256  256  32  64  256  256  32  128  256  256  32  64  512  256  32  32  256  256 TABLE VIII
Bactericidal AaidSy of Preimmune and Immune Serum of Subjea E.C,G. againa Various Meningococcal Strains
Meningococcal the immunoglobulin G class. They also demonstrated that the bactericidal spectrum of maternal and cord serum was identical, further evidence that immunoglobulin G antibody is primarily responsible for the meningococcocidal activity, since cord serum contains essentially only this kind of antibody (5) . In order to determine whether the artificially induced bactericidal activity mimicked the natural antibody response in this regard, an immune serum obtained from subject E. C. G. 37 wk after immunization with the A antigen was fractionated by gel filtration on Sephadex G-200. The elution profile is shown in Fig. 1 . The contents of the odd tubes were sterilized by filtration through Millipore filters and assayed for their ability to kill group A meningococci in the presence of exogenous complement. The eluates in the even tubes were assayed for the presence of hemagglutinating antibody. The bactericidal and hemagglutination titers are also entered in Fig. 1 .
The hemagglutinating activity was separated into two peaks, whereas the bactericidal activity was found solely in the second peak. The eluates in tubes 30, 48, and 60 were assayed for their content of immunoglobulin A, G, and M by quantitative radial immunodiffusion and these results are indicated in Table X .
It is clear from the elution profile and further confirmed by the results set forth in Table X that the bactericidal activity of this serum could be recovered in the irnmunoglobulin G fraction. The first peak containing immunoglobulin A and M had good hemagglutinating activity but no bactericidal power.
It should be mentioned that this serum also contained antibodies to the group C polysaccharide, and that the duates were tested for bactericidal activity against a group C test organism, and for hemagglutinating activity with red cells coated with C polysaccharide. Surprisingly, both of these activities were completely absent. It was then realized that the fractionating coblmn had been used previously to assay the gel filtration behavior of a preparation of group C polysaccharide, and evidently enough antigen had remained adsorbed to the column to completely remove all antibodies directed to this polysaccharide. * See Fig. 1 . The concentrations of immunoglobulins were measured by radial immunodiffusion.
DISCUSSION
More than a score of large scale attempts have been made to develop a vaccine to combat meningococcal meningitis (21) . Several of the vaccines were clearly ineffective, while others yielded inconclusive results. A vaccine prepared at the Pasteur Institute in Brazzaville from 1936 to 1939 was apparently successful. Unfortunately, the material produced by the same institute after World War II was no longer effective (21) . More recently, Greenberg and Cooper (22) produced a soluble vaccine which has protective power for mice.
The present study, which tests the antigenicity of high molecular weight group-specific meningococcal polysaccharides in man, represents a first step in the development of these polysaccharides as possible prophylactic immunizing agents. In the course of this study, the immunogenicity of four preparations of meningococcal polysaccharide were tested. None of these materials possessed significant toxicity for laboratory animals and no untoward reactions occurred among the six human volunteers. Subject J. W. had been a carrier of group C meningococci until 4 months preceding the study and had circulating antibodies to group C polysaccharide. His reaction to injection with group C polysaccharide did not differ from the other volunteers. Both the A and the C polysaccharides proved to be good immunogens in man. This result is at variance with previous experiments (7, 8) , but the polysaccharides tested prior to the present study were probably less than 50,000 average molecular weight (9). 1 It is our belief that the high molecular weight of the polysaccharides used in this study accounts for their immunogenicity, a hypothesis, which, however, has not been tested directly.
Antibodies belonging to each of the three major classes of immunoglobulins were produced in response to a single intradermal injection with 50 ~g of A or C polysaccharides. The sera of the six human volunteers became highly bactericidal after immunization, killing all strains of group A or group C organisms tested. Peak titers were reached within 2 wk and the levels of bactericidal activity remained essentially unchanged for 5 months. This finding is in agreement with the experience that the human precipitating antibody response elicited by purified polysaccharides is long lasting. Heidelberger (23) reports that detectable antibody to type-specific pneumococcal polysaccharide was usually still present 3 yr after immunization and frequently as late as 8 yr.
It was not possible to induce active immunity in mice with meningococcal polysaccharides, whereas this is readily accomplished with pneumococcal typespecific polysaccharides (20, 24) . It is not known whether this finding indicates that the meningococcal polysaccharides are not antigenic in the mouse, or that the deficiencies of the mucln-enhanced infection as an assay system negate the opportunity to observe an immune response. More sensitive methods for the detection of antibodies will have to be employed to settle this issue. An interesting development in this area is the recent study of Siskind et al. (25) employing isotopically labeled pneumococcal polysaccharide to measure quantitatively the immune response of the mouse. They found the greatest concentration of antibody about 1 wk after immunization and a slow decline thereafter. Their data indicate that the average immune response of the mouse is about 10 times less than the average human response to this antigen (26) .
The present study has also tested the immunogenicity of the meningococcal polysaccharides in several primate species. There was no evidence for antibody production in rhesus monkeys or in chimpanzees. One out of five gibbons responded, but the interpretation of such an isolated response is difficult. Study of the immunogenicity of meningococcal polysaccharides in this spedes should be pursued further.
A new immunizing agent which is to be considered seriously for field trials should have certain attributes, among which are immunogenicity and lack of significant toxicity. Furthermore, there need be indications that the antibodies elicited are likely to be protective. It is felt that the present report shows that the high molecular weight group-specific meningococcal polysaccharides fulfill these criteria and hence merit further attention to assess their value as prophylactic vaccines.
SUMMARY
High molecular weight group A and group C meningococcal polysaccharides had no significant toxicity for mice or guinea pigs. Furthermore, these polysac-charide preparations contained negligible amounts of biologically active endotoxin.
The high molecular weight group A and group C meningococcal polysaccharides were excellent immunogens in six human volunteers. Antibodies belonging to the immunoglobulin classes IgG, IgM, and IgA were produced.
These antibodies were highly meningococcocidal in the presence of complement.
